Protocol summary
-
Study aim
-
Comparing the Effect of Lavender and Rosemary Essential Oil Inhalation and the Simultaneous Use of These Two Scents on Sleep Quality, Anxiety and Depression in Patients Suffering from Coronary Artery Disease
-
Design
-
This single-blind randomised clinical trial study will have three intervention groups (lavender aromatherapy, rosemary aromatherapy and simultaneous aromatherapy with these two aromas) and a control group. The study phase is not applicable here. The randomization method will be block randomization on 148 patients.
-
Settings and conduct
-
Amol, Iran. single-blind (the data analyst and researcher will be blinded but the data collector and samples will not be blinded). The samples will be randomly divided into three intervention groups and one control group and will be exposed to the aromatic substance three times a day for 20 minutes by pouring 4 drops of the relevant aromatic oil on a piece of gauze and attaching it to the collar. It is done for 30 consecutive days. In the simultaneous aromatherapy group, two drops of lavender oil and two drops of rosemary oil and in the control group, a saline solution will be used.
-
Participants/Inclusion and exclusion criteria
-
Entry conditions: suffering from coronary artery disease, obtaining scores of greater than five from the PSQI sleep quality index, able to read and write, EF above 45%, access to social networks
Conditions not to enter: having a history of asthma, active mental illness, taking neuropsychiatric drugs, allergies to plants or any seasonal sensitivity, severe pain causing sleep disturbance, smell disturbance
-
Intervention groups
-
Aromatherapy with lavender, rosemary, Simultaneous aromatherapy with these two scents and control.
-
Main outcome variables
-
Anxiety, depression and sleep quality
General information
-
Reason for update
-
The title of the trial was modified due to an effort to choose a more attractive title for publication in reputable journals.
The sample size was reduced to 120 samples due to the lack of financial budget and the time limit in carrying out the project.
The timing of sampling was changed according to the changes made in the schedules of the respective universities.
The end time of the clinical trial was added.
By reviewing more literature, a saline solution (0.9% sodium chloride) was used instead of distilled water in the control group.
-
Acronym
-
-
IRCT registration information
-
IRCT registration number:
IRCT20230702058649N1
Registration date:
2024-02-10, 1402/11/21
Registration timing:
prospective
Last update:
2024-11-27, 1403/09/07
Update count:
1
-
Registration date
-
2024-02-10, 1402/11/21
-
Registrant information
-
-
Recruitment status
-
Recruitment complete
-
Funding source
-
-
Expected recruitment start date
-
2024-02-20, 1402/12/01
-
Expected recruitment end date
-
2024-06-20, 1403/03/31
-
Actual recruitment start date
-
2024-02-20, 1402/12/01
-
Actual recruitment end date
-
2024-06-25, 1403/04/05
-
Trial completion date
-
2024-07-25, 1403/05/04
-
Scientific title
-
Healing Aromas: The Effects of Lavender and Rosemary Essential Oils on Sleep Quality and Mental Well-Being in Coronary Artery Disease Patients: a Parallel Arm, Randomized, Controlled Trial
-
Public title
-
Effects of Lavender and Rosemary Essential Oils on Sleep Quality and Mental Well-Being in Coronary Artery Disease Patients
-
Purpose
-
Supportive
-
Inclusion/Exclusion criteria
-
Inclusion criteria:
Being diagnosed with coronary artery Disease
Having no history of neuropsychiatric disease by self report
Having no history of taking psychiatric medications
Normal olfactory function
Not using benzodiazepines, sedatives and narcotics
No history of asthma
No history of allergies to plants or any seasonal allergies
Absence of severe pain causes sleep disturbance
Obtaining scores of greater than five from the PSQI Sleep quality questionnaire
Having an ejection fraction above 45%
Being able to read and write
Access to social media
Exclusion criteria:
Acute pain at the time of completing the questionnaire
Any case that causes olfactory disorders during study
Showing an allergic reaction to the smell of essential oils
Showing discomfort with the smell of essential oils
Occurrence of life-threatening complications such as cardiopulmonary resuscitation
-
Age
-
No age limit
-
Gender
-
Both
-
Phase
-
N/A
-
Groups that have been masked
-
- Investigator
- Data analyser
-
Sample size
-
Target sample size:
148
Actual sample size reached:
120
-
Randomization (investigator's opinion)
-
Randomized
-
Randomization description
-
Eligible people will be selected by the available method and will be placed in three intervention groups and one control group using block randomization method. For this purpose, 37 blocks of 4 will be allocated using www.randomizer.org website, and each block will have 4 random numbers from 1 to 4. Then these blocks will be written on paper and sealed and then randomly one block will be chosen at each turn and people will enter the study in the order written on the paper. In fact, one block of four out of every 37 blocks of four will be randomly selected and the patients, as specified in the block, will divided into these groups: aromatherapy with lavender (1), aromatherapy with rosemary (2), simultaneous aromatherapy with these two aromas (3) and control (4). In this way, four patients (one patient in each group) will be examined each time. For the next time, another block is randomly selected and the patients are divided into one of the four study groups based on the selected block. Some blocks of four will be facing as follows: 2341, 1342, 1234.
-
Blinding (investigator's opinion)
-
Single blinded
-
Blinding description
-
In this study, the data analyst and the researcher who evaluates the results will be blinded and unaware of the nature of the groups, but the nurse assessor (data collector) will not be blinded. For this purpose, first of all, bottles containing essential oils and distilled water, which are completely similar in appearance, will be provided to the nurse evaluator, and she will randomly give them to the samples. without the researcher and data analyst knowing the nature of the groupings. It should be noted that the distinctive smell of essential oils makes it difficult to blind the study participants.
-
Placebo
-
Used
-
Assignment
-
Factorial
-
Other design features
-
Ethics committees
1
-
Ethics committee
-
-
Approval date
-
2023-10-25, 1402/08/03
-
Ethics committee reference number
-
IR.MAZUMS.REC.1402.441
Health conditions studied
1
-
Description of health condition studied
-
Coronary Artery disease
-
ICD-10 code
-
I20-I25
-
ICD-10 code description
-
Ischaemic heart diseases
Primary outcomes
1
-
Description
-
Depression score in Cardiac Depression Scale (CDS)
-
Timepoint
-
Before the intervention, 14 and 30 days after the start of the intervention
-
Method of measurement
-
Cardiac Depression Scale (CDS)
2
-
Description
-
Anxiety score in Hospital Anxiety and Depression Scale (HADS )
-
Timepoint
-
Before the intervention, 14 and 30 days after the start of the intervention
-
Method of measurement
-
Hospital Anxiety and Depression Scale (HADS )
3
-
Description
-
Sleep quality score in Pittsburgh Sleep Quality Index (PSQI)
-
Timepoint
-
Before the intervention, 14 and 30 days after the start of the intervention
-
Method of measurement
-
Pittsburgh Sleep Quality Index (PSQI)
Intervention groups
1
-
Description
-
First intervention group: Aromatherapy with lavender, samples will be exposed to the aromatic substance three times a day at 8 am, 3 pm and 10 pm for 20 minutes by pouring 4 drops of the relevant aromatic oil (provided by Barijesans Company) on a piece of gauze and attaching it to the patient's collar. This will be done for 30 consecutive days.
-
Category
-
N/A
2
-
Description
-
second intervention group: Aromatherapy with rosemary, samples will be exposed to the aromatic substance three times a day at 8 am, 3 pm and 10 pm for 20 minutes by pouring 4 drops of the relevant aromatic oil (provided by Barijesans Company) on a piece of gauze attached to the patient's collar. This will be done for 30 consecutive days.
-
Category
-
N/A
3
-
Description
-
The third intervention group: Simultaneous aromatherapy with rosemary and lavender, samples will be exposed to the aromatic substance three times a day at 8 am, 3 pm and 10 pm for 20 minutes by pouring 2 drops of lavender essential oil and 2 drops of rosemary essential oil (provided by Barijesans Company) on a piece of gauze attached to the patient's collar and this will be done for 30 consecutive days.
-
Category
-
N/A
4
-
Description
-
Control group: Samples will be exposed to the placebo substance three times a day at 8 am, 3 pm and 10 pm for 20 minutes by pouring 4 drops of saline solution on a piece of gauze and attaching it to the patient's collar and this will be done for 30 consecutive days.
-
Category
-
N/A
1
-
Sponsor
-
-
Grant name
-
-
Grant code / Reference number
-
-
Is the source of funding the same sponsor organization/entity?
-
Yes
-
Title of funding source
-
Mazandaran University of Medical Sciences
-
Proportion provided by this source
-
100
-
Public or private sector
-
Public
-
Domestic or foreign origin
-
Domestic
-
Category of foreign source of funding
-
empty
-
Country of origin
-
-
Type of organization providing the funding
-
Academic
Sharing plan
-
Deidentified Individual Participant Data Set (IPD)
-
Yes - There is a plan to make this available
-
Study Protocol
-
Yes - There is a plan to make this available
-
Statistical Analysis Plan
-
Yes - There is a plan to make this available
-
Informed Consent Form
-
Yes - There is a plan to make this available
-
Clinical Study Report
-
Yes - There is a plan to make this available
-
Analytic Code
-
Undecided - It is not yet known if there will be a plan to make this available
-
Data Dictionary
-
Undecided - It is not yet known if there will be a plan to make this available
-
Title and more details about the data/document
-
All demographic information, sleep quality, depression and anxiety of the samples
-
When the data will become available and for how long
-
accessible from 2024
-
To whom data/document is available
-
The data will be accessible to researchers working in academic and scientific institutions.
-
Under which criteria data/document could be used
-
The data will be used in secondary data analysis or meta-analysis studies.
-
From where data/document is obtainable
-
Address of the University: The Headquarters of Mazandaran University of Medical Sciences and Health Services, the beginning of ValiAsr Highway (AJ), Sari
Postal code: 48157-33971
Contact phone numbers: 09811-33044000 and 09811-33044001
Contact number of Research and Technology Unit: 09811-34484800
Email of Research and Technology Unit: pajhoheshi@mazums.ac.ir
Assistant of Research and Technology Unit: Dr. Pedram Ebrahimnejad
-
What processes are involved for a request to access data/document
-
At first, official request will be sent from the applicant organization to Mazandaran University of Medical Sciences, and if there is no legal prohibition, the information will be provided to the researcher with the coordination and permission of the university's Research and Technology Unit.
-
Comments
-